ninety-two microbiologically documented staphylococcal infections were treated with cefamandole in an open comparative study on the clinical efficacy of this cephalosporin in the therapy of infections caused by both methicillin-susceptible and methicillin-resistant staphylococcus aureus and coagulase-negative staphylococcus spp .
C0038160
staphylococcal infections
C0007541
cefamandole